What is a 'Sweetheart Deal'

A sweetheart deal is an agreement of any type, including mergers and acquisitions (M&A), in which one party presents another party with very attractive terms and conditions — usually so lucrative that it is difficult to refuse the offer.

Numerous types of business transactions may be termed sweetheart deals. They may occur for a variety of reasons and are subject to different interpretations. For example, the term could describe all manner of insider trading or it could mean a slap-on-the-hand or look-the-other-way from an authority when an entity has done something dishonorable, instead of the authority meeting out due punishment.

In any case, when one uses the term “sweetheart” to describe a deal, it often carries the implication that something unethical or fishy is afoot.

Breaking down 'Sweetheart Deal'

Sweetheart deal can also infer an arrangement in which you get something that is to your advantage, but only by agreeing to give up something else. In yet another interpretation, it could mean an agreement between two organizations that offers advantages to both, but which is unfair to competitors or another third party.

In an M&A deal, or an attempt to lure a new executive with bonuses and perks, for example, the deal might be “sweet” for the key players because they can get very healthy buyout packages. However, a restructuring might result in layoffs for many lower-level employees.

Shareholders Beware

A sweetheart deal often, but not always, can be bad for shareholders. These deals can be very costly to execute, with steep legal fees and the like. If a company does not put its shareholders’ interests first, using its money instead to fund the deal, then shareholders could take a financial hit. But because an issuer has a fiduciary duty to its shareholders, if a sweetheart deal is obviously unethical and not in shareholders' interests, then legal action may be taken. Shareholders also could suffer a loss if the market reacts badly to the deal, and the stock price falls.

A Real-Life Sweetheart Deal

Early in 2017, the press learned that then-President Donald Trump’s nominee for secretary of the United States Department of Health and Human Services (HHS), which regulates pharmaceuticals, got a discounted deal on stock from an Australian biotechnology firm seeking U.S. Food and Drug Administration (FDA) approval for its new drug.

Innate Immunotherapeutics (Innate Immuno) needed to raise money. But instead of issuing stock in the open market, it offered a sweetheart deal to a couple of “sophisticated” U.S. investors — selling nearly $1 million in discounted shares to two American congressmen who had the potential to advance Innate Immuno’s interests. One of these congressmen was the HHS nominee cited above; the second — who also happened to own about 20 percent of Innate Immuno — sat on a key health subcommittee. These congressmen investors paid 18 cents per share for stake in a company whose value at the time had risen rapidly to more than 90 cents and was climbing higher. Ultimately, on paper, these buyers realized a greater-than 400 percent profit!

The “sweetheart” portion of this deal is obvious: It 1) skirted normal procedures; 2) contained grave conflicts of interest; 3) solicited industry insiders, who also were well-placed politicians; and 4) benefited (greatly) only a handful of people at the top.

This stock deal famously resurrected concern about powerful public officials being privy to investment opportunities that are not available to the public, including from companies whose profits might be influenced by political decisions.

RELATED TERMS
  1. Shareholders' Agreement

    A shareholders' agreement is an arrangement among a company's ...
  2. Common Shareholder

    The rights of common shareholders give shareholders the ability ...
  3. PIPE Deal

    Signifying "Private Investment in Public Equity," a PIPE deal ...
  4. All Cash, All Stock Offer

    An all cash, all stock offer is a proposal by one company to ...
  5. Shareholder Register

    A shareholder register is a list of active owners of a company's ...
  6. Agency Costs

    Agency Costs are a type of internal cost that arises from, or ...
Related Articles
  1. Investing

    6 Terms To Warm The Coldest Wall Street Heart

    There is plenty of love on Wall Street, even if it's all just words.
  2. Financial Advisor

    Acquire a career in mergers

    This exciting sector demands a lot from its advisors. Are you up for it?
  3. Managing Wealth

    The Top Reasons Why M&A Deals Fail

    A significant number of M&A transactions result in failure. Here are the top reasons why it happens.
  4. Financial Advisor

    4 Trends Driving M&A in the Healthcare Industry in 2015

    Learn why there has been a lot of mergers and acquisition activity among health insurers and drug companies in the health care industry in 2015.
  5. Financial Advisor

    Asset, Wealth Manager M&A Was Up in Q3; Value Fell

    The third quarter of 2016 saw an increase in M&A activity among asset and wealth managers says a new report, but the value of the deals is down.
  6. Investing

    Know your shareholder rights

    Common-stock owners have numerous privileges and should be vigilant in monitoring a company. Read on to learn what rights you have as a shareholder.
  7. Investing

    How Biotech Companies Expecting M&A Deals Can Offer High Returns (ABT, STJ)

    With a 35% decline, consolidation appears imminent in the biotech sector. Here are the potential M&A candidates and how to benefit from high returns.
  8. Investing

    When Good News Is Actually Bad News For Investors

    Learn how investors can be on the lookout for companies that spin bad news for shareholders into good news. Watch out for these types of announcements.
  9. Insights

    M&A Boom in 2017 Seen Spawning Record-Size Deals

    Booming M&A may spawn the first $100 billion all-cash deal, JPMorgan says
RELATED FAQS
  1. What is the difference between an accretive and a dilutive merger?

    Learn how to distinguish between a merger and acquisition (M&A) deal that is accretive and one that is dilutive, and why ... Read Answer >>
  2. What's a Typical Day for Someone in M&A?

    Financial professionals in M&A have a very specialized role. Check out their typical duties. Read Answer >>
  3. Why Isn't My Stock Trading at the Buyout Price?

    An acquisition or merger does not necessarily mean the deal will be resolved as originally stated. Read Answer >>
  4. How Privatization Affect's a Company's Shareholders?

    Here's how shareholders of a public company can benefit if the company is taken private at a premium to where they own the ... Read Answer >>
  5. How does a merger affect the shareholders?

    Explore the impact of a merger and understand how the process affects shareholders of the newly merged firm in terms of stock ... Read Answer >>
  6. All-stock vs All-cash M&A deal

    Mergers and acquisitions are becoming increasingly popular forms of corporate restructuring. Learn how it can affect the ... Read Answer >>
Trading Center